Downregulation of miR-145 leads to enhanced tumor growth, invasion, metastasis, and cancer stem cell (CSC) proliferation, while inhibition of PI3K/Akt signaling has been associated with reduced multidrug resistance and improved responses to cisplatin treatment [31]. This evidence concerns the gene AKT1 and cancer.